These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 17598019

  • 1. PFA-100 closure times in preoperative screening in 500 pediatric patients.
    Roschitz B, Thaller S, Koestenberger M, Wirnsberger A, Leschnik B, Fritsch P, Muntean W.
    Thromb Haemost; 2007 Jul; 98(1):243-7. PubMed ID: 17598019
    [Abstract] [Full Text] [Related]

  • 2. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML.
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
    Favaloro EJ, Zafer M, Nair SC, Hertzberg M, North K.
    Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
    [Abstract] [Full Text] [Related]

  • 4. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH, Kappers-Klunne MC, Leebeek FW, Michiels JJ.
    Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
    [Abstract] [Full Text] [Related]

  • 5. [Preoperative identification of patients with impaired (primary) haemostasis. A practical concept].
    Koscielny J, Ziemer S, Radtke H, Schmutzler M, Kiesewetter H, Salama A, von Tempelhoff GF.
    Hamostaseologie; 2007 Aug; 27(3):177-84. PubMed ID: 17694224
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A, Kerenyi A, Muszbek L, Boda Z.
    Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
    [Abstract] [Full Text] [Related]

  • 7. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults.
    Harrison P.
    Br J Haematol; 2005 Jul; 130(1):3-10. PubMed ID: 15982339
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL, Rolf N, Loesel A, Kuhlisch E, Siegert G, Knoefler R.
    Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
    [Abstract] [Full Text] [Related]

  • 9. Acquired Von Willebrand disease in children with a Wilms' tumor.
    Jonge Poerink-Stockschlader AB, Dekker I, Risseeuw-Appel IM, Hählen K.
    Med Pediatr Oncol; 1996 Apr; 26(4):238-43. PubMed ID: 8600334
    [Abstract] [Full Text] [Related]

  • 10. Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting.
    Rand ML, Carcao MD, Blanchette VS.
    Semin Thromb Hemost; 1998 Apr; 24(6):523-9. PubMed ID: 10066147
    [Abstract] [Full Text] [Related]

  • 11. A practical concept for preoperative identification of patients with impaired primary hemostasis.
    Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P, Salama A, Kiesewetter H, Latza R.
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):195-204. PubMed ID: 15247976
    [Abstract] [Full Text] [Related]

  • 12. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I, Morris D, Konkle BA.
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [Abstract] [Full Text] [Related]

  • 13. Use of the platelet function analyzer to minimize bleeding complications after renal biopsy.
    van den Hoogen MW, Verbruggen BW, Polenewen R, Hilbrands LB, Nováková IR.
    Thromb Res; 2009 Jan; 123(3):515-22. PubMed ID: 18703219
    [Abstract] [Full Text] [Related]

  • 14. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Jan; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 15. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
    Philipp CS, Miller CH, Faiz A, Dilley A, Michaels LA, Ayers C, Bachmann G, Dowling N, Saidi P.
    Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
    [Abstract] [Full Text] [Related]

  • 16. [Haemostatic testing prior to elective surgery? Yes!].
    Albert FW, Eichler H, Haubelt H, Loreth R, Matzdorff A, Peetz D, Pindur G, Schinzel H, Seyfert U, Hellstern P, für das Kompetenznetz Hämostaseologie Rheinland-Pfalz-Saarland.
    Hamostaseologie; 2009 Jan; 29(1):58-63. PubMed ID: 19151848
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the new INNOVANCE® PFA P2Y cartridge in patients with impaired primary haemostasis.
    Koessler J, Ehrenschwender M, Kobsar A, Brunner K.
    Platelets; 2012 Jan; 23(8):571-8. PubMed ID: 22185369
    [Abstract] [Full Text] [Related]

  • 18. Preoperative history and coagulation screening in children undergoing tonsillectomy.
    Burk CD, Miller L, Handler SD, Cohen AR.
    Pediatrics; 1992 Apr; 89(4 Pt 2):691-5. PubMed ID: 1557263
    [Abstract] [Full Text] [Related]

  • 19. Is the activated partial thromboplastin time suitable to screen for von Willebrand factor deficiencies?
    Lippi G, Franchini M, Poli G, Salvagno GL, Montagnana M, Guidi GC.
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):361-4. PubMed ID: 17473578
    [Abstract] [Full Text] [Related]

  • 20. The prevalence of bleeding disorders among healthy pediatric patients with abnormal preprocedural coagulation studies.
    Shaw PH, Reynolds S, Gunawardena S, Krishnamurti L, Ritchey AK.
    J Pediatr Hematol Oncol; 2008 Feb; 30(2):135-41. PubMed ID: 18376266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.